Loading...
Please wait, while we are loading the content...
Similar Documents
Clinically indicated ibrutinib dose interruptions and reductions do not compromise long-term outcomes in CLL
| Content Provider | Scilit |
|---|---|
| Author | Ahn, Inhye E. Basumallik, Neil Tian, Xin Soto, Susan Wiestner, Adrian |
| Copyright Year | 2019 |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543520/pdf |
| Ending Page | 2455 |
| Page Count | 4 |
| Starting Page | 2452 |
| DOI | 10.1182/blood.2019896688 |
| Journal | Blood |
| Issue Number | 22 |
| Volume Number | 133 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2019-05-30 |
| Access Restriction | Open |
| Subject Keyword | Health Policy and Services Journal: Blood (Vol- 136, Issue- 22) |
| Content Type | Text |
| Resource Type | Article |